Correlation Between Monopar Therapeutics and Hookipa Pharma
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and Hookipa Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and Hookipa Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and Hookipa Pharma, you can compare the effects of market volatilities on Monopar Therapeutics and Hookipa Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of Hookipa Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and Hookipa Pharma.
Diversification Opportunities for Monopar Therapeutics and Hookipa Pharma
-0.75 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Monopar and Hookipa is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and Hookipa Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hookipa Pharma and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with Hookipa Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hookipa Pharma has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and Hookipa Pharma go up and down completely randomly.
Pair Corralation between Monopar Therapeutics and Hookipa Pharma
Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 1.31 times more return on investment than Hookipa Pharma. However, Monopar Therapeutics is 1.31 times more volatile than Hookipa Pharma. It trades about 0.09 of its potential returns per unit of risk. Hookipa Pharma is currently generating about -0.49 per unit of risk. If you would invest 1,783 in Monopar Therapeutics on August 28, 2024 and sell it today you would earn a total of 157.00 from holding Monopar Therapeutics or generate 8.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Monopar Therapeutics vs. Hookipa Pharma
Performance |
| Timeline |
| Monopar Therapeutics |
| Hookipa Pharma |
Monopar Therapeutics and Hookipa Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monopar Therapeutics and Hookipa Pharma
The main advantage of trading using opposite Monopar Therapeutics and Hookipa Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, Hookipa Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hookipa Pharma will offset losses from the drop in Hookipa Pharma's long position.| Monopar Therapeutics vs. Eliem Therapeutics | Monopar Therapeutics vs. HCW Biologics | Monopar Therapeutics vs. Scpharmaceuticals | Monopar Therapeutics vs. Milestone Pharmaceuticals |
| Hookipa Pharma vs. Mereo BioPharma Group | Hookipa Pharma vs. Terns Pharmaceuticals | Hookipa Pharma vs. PDS Biotechnology Corp | Hookipa Pharma vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |